Targeting the Mevalonate Pathway for Treating Esophageal Cancer

被引:0
|
作者
Jonathan V. S. Wong
Ali Fatehi Hassanabad
机构
[1] University of Calgary,Cumming School of Medicine, Medical Centre
来源
关键词
Esophageal cancer; Statins; Translational research; Preclinical studies;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:819 / 821
页数:2
相关论文
共 50 条
  • [21] The mevalonate synthesis pathway as a therapeutic target in cancer
    Andela, VB
    Pirri, M
    Schwarz, EM
    Puzas, EJ
    O'Keefe, RJ
    Rosenblatt, JD
    Rosier, RN
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2003, (415) : S59 - S66
  • [22] The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
    Guerra, Borja
    Recio, Carlota
    Aranda-Tavio, Haidee
    Guerra-Rodriguez, Miguel
    Garcia-Castellano, Jose M.
    Fernandez-Perez, Leandro
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Targeting the HMG-CoA Synthase-Mevalonate Pathway Sensitises Breast Cancer Cells to Tamoxifen
    Russell, A.
    Cummings, M.
    Pollock, S.
    Speirs, V.
    JOURNAL OF PATHOLOGY, 2011, 224 : S8 - S8
  • [24] Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer
    Sethunath, Vidyalakshmi
    Hu, Huizhong
    De Angelis, Carmine
    Veeraraghavan, Jamunarani
    Qin, Lanfang
    Wang, Nicholas
    Simon, Lukas M.
    Wang, Tao
    Fu, Xiaoyong
    Nardone, Agostina
    Pereira, Resel
    Nanda, Sarmistha
    Griffith, Obi L.
    Tsimelzon, Anna
    Shaw, Chad
    Chamness, Gary C.
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Heiser, Laura M.
    Hilsenbeck, Susan G.
    Huang, Shixia
    Rimawi, Mothaffar F.
    Gray, Joe W.
    Osborne, C. Kent
    Schiff, Rachel
    MOLECULAR CANCER RESEARCH, 2019, 17 (11) : 2318 - 2330
  • [25] Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer
    Honjo, Soichiro
    Ajani, Jaffer A.
    Scott, Ailing W.
    Chen, Qiongrong
    Skinner, Heath D.
    Stroehlein, John
    Johnson, Randy L.
    Song, Shumei
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 567 - 574
  • [26] Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
    Laka, Kagiso
    Makgoo, Lilian
    Mbita, Zukile
    FRONTIERS IN GENETICS, 2022, 13
  • [27] Strategies to enhance epidermal growth factor inhibition: Targeting the mevalonate pathway
    Dimitroulakos, Jim
    Lorimer, Ian A.
    Goss, Glenwood
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4426S - 4431S
  • [28] Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor
    Mantha, AJ
    Hanson, JEL
    Goss, G
    Lagarde, AE
    Lorimer, IA
    Dimitroulakos, J
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2398 - 2407
  • [29] Therapeutic targeting of the mevalonate–geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer
    Chenchen Guo
    Ruijie Wan
    Yayi He
    Shu-Hai Lin
    Jiayu Cao
    Ying Qiu
    Tengfei Zhang
    Qiqi Zhao
    Yujia Niu
    Yujuan Jin
    Hsin-Yi Huang
    Xue Wang
    Li Tan
    Roman K. Thomas
    Hua Zhang
    Luonan Chen
    Kwok-Kin Wong
    Liang Hu
    Hongbin Ji
    Nature Cancer, 2022, 3 : 614 - 628
  • [30] Treating cancer by targeting a weakness
    Brody, LC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (09): : 949 - 950